Brenda M. Acosta Ashby, MD
NPI 1366480386ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Doral, FL
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Doral, Florida, licensed in FL, with an NPI issued in June 2006. Part D covered 63 prescriptions written in 2024, 49% of them generic. Novo Nordisk Inc reported $120.20 in payments in 2025, mostly food and beverage.
Overview
| NPI | 1366480386 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Jun 3, 2006 |
| Last updated in NPPES | Mar 28, 2014 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | ME95818 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Endocrinology (FL) |
|---|
Part D prescriptions in 2024
| Prescriptions (claims) | 63 · 185 30-day fills |
|---|---|
| Total drug cost | $40,454 |
| Generic share | 49% of claims |
Industry payments (Open Payments)
- 2025$120.20 · 1 payment from 1 company
- 2024$76.76 · 3 payments from 2 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $120.20 | 1 |
What the 2025 payments were for
- Food and Beverage$120.20 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other endocrinologists in Doral
- 1225156565
- 1760090740
- 1164865143
- 1447485446
- 1396568085
- 1396591962
- 1609448984
- 1992646913